Korro Bio, Inc. (KRRO)
(Delayed Data from NSDQ)
$36.36 USD
+0.39 (1.08%)
Updated Aug 13, 2024 04:00 PM ET
After-Market: $36.15 -0.21 (-0.58%) 7:20 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for Korro Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -81.17 | -81.58 | -84.69 | -26.51 | -18.75 |
Depreciation/Amortization & Depletion | 3.55 | 2.77 | 2.78 | 1.15 | 0.81 |
Net Change from Assets/Liabilities | 4.28 | -2.02 | -17.33 | -30.24 | 48.65 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.06 | 22.60 | 23.18 | 10.42 | 3.50 |
Net Cash From Operating Activities | -67.28 | -58.24 | -76.06 | -45.19 | 34.22 |
Property & Equipment | -7.84 | 0.02 | -2.91 | -6.67 | -1.06 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 19.00 | 31.12 | -63.21 | 17.07 | -17.20 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 11.16 | 31.13 | -66.13 | 10.40 | -18.26 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 163.41 | 0.26 | 1.36 | 1.55 | 142.02 |
Issuance (Repayment) of Debt | 0.00 | -0.83 | 0.00 | 15.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 24.35 | 0.00 | 0.00 | 40.14 | 0.00 |
Net Cash from Financing Activities | 187.76 | -0.58 | 1.36 | 56.69 | 142.02 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 131.64 | -27.68 | -140.83 | 21.90 | 157.97 |
Cash at Beginning of Period | 41.48 | 81.33 | 222.16 | 200.26 | 42.19 |
Cash at End of Period | 173.12 | 53.65 | 81.33 | 222.16 | 200.16 |
Diluted Net EPS | -53.08 | -116.50 | -123.50 | -41.00 | -114.50 |
Fiscal Year End for Korro Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -19.56 | -81.17 | -41.95 | -30.34 |
Depreciation/Amortization & Depletion | NA | 0.73 | 3.55 | 1.88 | 1.49 |
Net Change from Assets/Liabilities | NA | -5.13 | 4.28 | 1.78 | -1.08 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 2.07 | 6.06 | 10.94 | 7.37 |
Net Cash From Operating Activities | NA | -21.89 | -67.28 | -27.36 | -22.56 |
Property & Equipment | NA | -5.61 | -7.84 | -0.04 | -0.08 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 19.00 | 31.57 | 24.79 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -5.61 | 11.16 | 31.53 | 24.71 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.14 | 163.41 | 0.03 | 0.03 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | -14.17 | -14.17 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 24.35 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.14 | 187.76 | -14.13 | -14.14 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -27.36 | 131.64 | -9.96 | -11.98 |
Cash at Beginning of Period | NA | 173.12 | 41.48 | 53.65 | 53.65 |
Cash at End of Period | NA | 145.76 | 173.12 | 43.69 | 41.67 |
Diluted Net EPS | NA | -2.44 | 4.92 | -15.50 | -15.00 |